Psychiatry Research
Volume 170, Issue 2 , Pages 290-291 , 30 December 2009

The use of oral contraceptives as a prevention of recurrent premenstrual psychosis

  • Marta Coromina Sadurni

      Affiliations

    • Sant Joan de Déu-Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    • Corresponding Author InformationCorresponding author.
    • ,
  • Judith Usall Rodie

      Affiliations

    • Sant Joan de Déu-Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain
    • ,
  • Laia Miquel de Montagut

      Affiliations

    • Sant Joan de Déu-Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
    • ,
  • Mònica Sánchez Autet

      Affiliations

    • Sant Joan de Déu-Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain

Received 5 September 2008 ,Revised 10 February 2009 ,Accepted 22 February 2009.

References 

  1. Bäckström T, Hammarbäck S. Premenstrual syndrome—psychiatric or gynaecological disorder?. Annals of Medicine. 1991;23(6):625–633
  2. Birmingham MK, Barta A, Solyom L, Lehoux JG, Vecsei P. Correlations between mood scores, LH, adrenocortical steroids, and urine volumes in a patient with a history of postpartum depression and monthly psychotic episodes. Endocrine Research. 1998;24(3–4):595–599
  3. Brockington I. Menstrual psicosis. World Psychiatry. 2005;4(1):9–17
  4. Choi SH, Kang SB, Joe SH. Changes in premenstrual symptoms in women with schizophrenia: a prospective study. Psychosomatic Medicine. 2001;63:822–829
  5. Deuchar N, Brockington I. Puerperal and menstrual psychoses: the proposal of a unitary etiological hypothesis. Journal of Psychosomatic Obstetrics and Gynaecology. 1998;19:104–110
  6. Felthous AR, Robinson DB, Conroy RW. Prevention of recurrent menstrual psychosis by an oral contraceptive. American Journal of Psychiatry. 1980;137(2):245–246
  7. Fink G, Sumner BE, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: effect on mood, mental state and memory. Cellular and Molecular Neurobiology. 1996;16(16):325–344
  8. Halbreich U, Kahn LS. Hormonal aspects of schizophrenias: an overview. Psychoneuroendocrinology. 2003;28:1–16
  9. Hallonquist JD, Seeman MV, Lang M, Rectot NA. Variation in symptom severity over the menstrual cycle of schizophrenics. Biological Psychiatry. 1993;33:207–209
  10. Huber JC, Heskamp ML, Schramm GA. Effect of an oral contraceptive with chlormadinone acetate on depressive mood: analysis of data from four observational studies. Clinical Drug Investigation. 2008;28(12):783–791
  11. Lindamer LA, Lohr JB, Harris MJ, Jeste DV. Gender, estrogen, and schizophrenia. Psychopharmacology Bulletin. 1997;33(2):221–228
  12. Stein D, Blumensohn R, Witztum E. International Journal of Psychiatry in Medicine. 2003;33(2):169–179

PII: S0165-1781(09)00091-2

doi: 10.1016/j.psychres.2009.02.015

Psychiatry Research
Volume 170, Issue 2 , Pages 290-291 , 30 December 2009

Article Tools